Sunday, October 1, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from CSL Behring.
Steering Committee Member Chair
Professor
Department of Medicine
Division of Pulmonary, Allergy,
and Critical Care Medicine
Professor
Department of Pediatrics
Penn State Hershey Allergy, Asthma
and Immunology
Penn State University
Hershey, Pennsylvania, United States
Honorary Consultant Clinical Immunologist
Immunology Department
Barts and The London NHS Trust
Leeds, United Kingdom
Clinical Professor of Internal Medicine
University of Texas
Southwestern Medical School
Dallas, Texas, United States
Professor
Department of Dermatology, Venereology,
and Allergology
Charité - Universitätsmedizin Berlin
Berlin, Germany
Professor of Dermatology
Director of Research
Department of Dermatology and Allergy
Head
Specialty Clinics for Urticaria, Mastocytosis, Pruritus
and Angioedema
Allergie-Centrum-Charité
Charité - Universitätsmedizin Berlin
Berlin, Germany
Director
US HAE Angioedema Center
Chief
Division of Rheumatology, Allergy,
and Immunology
Department of Medicine
University of California, San Diego
San Diego, California, United States
Steering Committee Member
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Biocryst Pharmaceuticals, Inc.; BioMarin Pharmaceutical Inc.; CSL Behring; Grifols; Regeneron Pharmaceuticals, Inc.; Takeda
Speaker or member of speakers bureau for: CSL Behring; Grifols; Takeda
Research funding from: Biocryst Pharmaceuticals, Inc.; BioMarin Pharmaceutical Inc.; CSL Behring; GlaxoSmithKline; Grifols; Ionis Pharmaceuticals; Kalistor; Pharvaris; Regeneron Pharmaceuticals, Inc.; Takeda
Has disclosed the following relevant financial relationships:
Consultant or advisor for: BioCryst Pharmaceuticals, Inc.; CSL Behring; Intellia; KalVista Pharmaceuticals; Pharming Group NV; Pharvaris; Takeda
Speaker or member of speakers bureau for: CSL Behring; Intellia; Pharming Group NV; Takeda
Research funding from: BioCryst Pharmaceuticals, Inc.; CSL Behring; Intellia; KalVista Pharmaceuticals; Pharming Group NV; Pharvaris; Takeda
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Astria; BioCryst Pharmaceuticals, Inc.; BioMarin Pharmaceutical Inc.; CSL Behring; CVS; Express Scripts; Fresenius Kabi; Intellia; KalVista Pharmaceuticals; Magellan; Optum; Pharming Group NV; Pharvaris; Shire; Takeda
Speaker or member of speakers bureau for: AstraZeneca; BioCryst Pharmaceuticals, Inc.; CSL Behring; GlaxoSmithKline; Grifols; OptiNose US Inc.; Pharming Group NV; Regeneron Pharmaceuticals, Inc.; Sanofi; Shire; Takeda
Research funding from: BioMarin Pharmaceutical Inc.; CSL Behring; Grifols; Ionis Pharmaceuticals; KalVista Pharmaceuticals; Shire; Takeda; Teva
Contracted researcher for: BioMarin Pharmaceutical Inc.; CSL Behring; Grifols; Ionis Pharmaceuticals; KalVista Pharmaceuticals; Shire; Takeda; Teva
Has disclosed the following relevant financial relationships:
Consultant or advisor for: BioCryst Pharmaceuticals, Inc.; CSL Behring; Dyax Corp.; Jerini AG; KalVista Pharmaceuticals; Octapharma; Pharming Group NV; Pharvaris; Shire; Takeda
Speaker or member of speakers bureau for: BioCryst Pharmaceuticals, Inc.; CSL Behring; Dyax Corp.; Jerini AG; KalVista Pharmaceuticals; Octapharma; Pharming Group NV; Pharvaris; Shire; Takeda
Research funding from: BioCryst Pharmaceuticals, Inc.; CSL Behring; Dyax Corp.; Jerini AG; KalVista Pharmaceuticals; Octapharma; Pharming Group NV; Pharvaris; Shire; Takeda
Contracted researcher for: BioCryst Pharmaceuticals, Inc.; CSL Behring; KalVista Pharmaceuticals; Pharvaris; Takeda
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Alnylam Pharmaceuticals, Inc.; BioCryst Pharmaceuticals, Inc.; Centogene; CSL Behring; Dyax Corp.; KalVista Pharmaceuticals; Pharming Group NV; Pharvaris; Shire; Takeda
Speaker or member of speakers bureau for: Alnylam Pharmaceuticals, Inc.; BioCryst Pharmaceuticals, Inc.; Centogene; CSL Behring; Dyax Corp.; KalVista Pharmaceuticals; Pharming Group NV; Pharvaris; Shire; Takeda
Research funding from: Alnylam Pharmaceuticals, Inc.; BioCryst Pharmaceuticals, Inc.; Centogene; CSL Behring; Dyax Corp.; KalVista Pharmaceuticals; Pharming Group NV; Pharvaris; Shire; Takeda
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BioCryst Pharmaceuticals, Inc.; BioMarin Pharmaceutical Inc.; CSL Behring; Genetech; Novartis; Takeda
Contracted researcher for: Ionis Pharmaceuticals